NOVAVAX : Réponse à un mail envoyé à NVAX!!!>>>

Profil supprimé

02 nov. 2009 •15:26

Good morning Didier

Novavax does not use an adjuvant in their vaccine. Thank you for your interest in Novavax.

Kind regards

Tricia

Tricia J. Richardson
Senior Manager, Investor Relations
Novavax, Inc.
9920 Belward Campus Drive
Rockville, MD 20850
Direct Line: 240 268 2031
Direct e-fax: 240 268 2131
email: trichardson@novavax.com
www.novavax.com
Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based highly potent, recombinant vaccines utilizing a new, efficient manufacturing solution.


-----Original Message-----

Sent: Monday, November 02, 2009 8:52 AM
To: Investor Relations
Subject: Adjuvants/ Vaccines Novavax


Hello Miss Richardson,

I am Belgian Novavax shareholder with 1,200 stocks.

There is a strong argument in Belgium and many other countries about the
danger of adjuvants for vaccine against H1N1 influenza
(Squalène/Thimerosal for example) of GSK.

Novavax uses adjuvants in their vaccines? And if so, which? Then I know
this information?

Kindest Regards